The aim of this prospective, multi-centre, exploratory research project is the establishment of a platform for in-depth tumour profiling in patients with advanced and metastatic High-Grade Adenocarcinoma (HGAC) of ovarian, tubal or peritoneal origin.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Sample Processing and Report Generation (1)
Timeframe: Through study completion, an average of 1 year
Sample Processing and Report Generation (2)
Timeframe: Through study completion, an average of 1 year
Sample Processing and Report Generation (3)
Timeframe: Through study completion, an average of 1 year
Sample Processing and Report Generation (4)
Timeframe: Through study completion, an average of 1 year
Sample Processing and Report Generation (5)
Timeframe: Through study completion, an average of 1 year
Sample Processing and Report Generation (6)
Timeframe: Through study completion, an average of 1 year
Sample Processing and Report Generation (7)
Timeframe: Through study completion, an average of 1 year
Classification of Proposed Treatment Options
Timeframe: Through study completion, an average of 1 year
Classification of Tumour Board Recommendations
Timeframe: Through study completion, an average of 1 year
Time to first subsequent treatment (TTFST)
Timeframe: Through study completion, at least 6 month of follow up
Time to first subsequent treatment (TTFST) ratio
Timeframe: Through study completion, at least 6 month of follow up
Terminations due to toxicity
Timeframe: Through study completion, at least 6 month of follow up
Survival
Timeframe: Through study completion, at least 6 month of follow up
Event free survival (EFS)
Timeframe: Through study completion, at least 6 month of follow up
Radiological tumour response
Timeframe: Through study completion, at least 6 month of follow up
Quality of Life (FAC-G7) questionnaire
Timeframe: Every 12 weeks (+/- 2 weeks) for 6 months after last tumour sampling (day 0)